AVID BIOSERVICES, IN

CDMO
Delayed Quote. Delayed  - 08/07 04:00:00 pm
7.73USD +0.78%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

Number of employees : 222 people.
Sales per Business
20192020
USD
(in Million)
%USD
(in Million)
%
Manufacturing 43.4381% 52.0587.2%
Process Development 10.1719% 7.6612.8%
Sales per region
20192020
USD
(in Million)
%USD
(in Million)
%
United States 53.60100% 59.70100%
Managers
Name Title
Nicholas Green President, Chief Executive Officer & Director
Joseph Carleone Non-Executive Chairman
Richard A. Richieri Chief Operating Officer
Daniel Ryan Hart Chief Financial Officer
Nick Ferguson Executive Director-Information Technology
Mark R. Bamforth Independent Director
Patrick D. Walsh Independent Director
Gregory P. Sargen Independent Director
Richard B. Hancock Director
Catherine J. Mackey Independent Director
Shareholders
Name Equities %
IsZo Capital Management LP 5,645,701 10.00%
Eastern Capital Ltd. 4,300,993 7.61%
Tappan Street Partners LLC 4,115,000 7.29%
Millennium Management LLC 2,992,385 5.30%
The Vanguard Group, Inc. 2,527,038 4.47%
Snyder Capital Management LP 2,280,905 4.04%
AltraVue Capital LLC 1,933,815 3.42%
BlackRock Fund Advisors 1,645,224 2.91%
Sargent Investment Group LLC 1,165,997 2.06%
SSgA Funds Management, Inc. 1,038,673 1.84%
Company contact information
Avid Bioservices, Inc.
2642 Michelle Drive
Suite 200
Tustin, CA 92780-7017

Phone : +1.714.508.6100
Fax : +1.714.838.5817
Web : http://avidbio.com
Sector Biopharmaceuticals
1st jan.Capi. (M$)
AVID BIOSERVICES, INC.-4.45%437
CSL LIMITED-0.57%89 334
BIOGEN INC.3.03%48 398
SAMSUNG BIOLOGICS CO.,LTD.77.37%42 742
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.224.31%36 982
WUXI BIOLOGICS (CAYMAN) INC.72.33%29 772
UCB46.05%23 083
SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.168.72%22 769
ALEXION PHARMACEUTICALS-4.50%22 636
BIOMARIN PHARMACEUTICAL INC.40.35%21 521
GRIFOLS-21.38%17 169
CELLTRION HEALTHCARE CO LTD--.--%13 444
SHANGHAI JUNSHI BIOSCIENCES CO., LTD.91.20%12 662
INNOVENT BIOLOGICS, INC.88.51%9 039
BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.106.11%8 640
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO., LTD78.20%7 595
CANSINO BIOLOGICS INC.308.82%6 923
ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD.43.74%4 769
SHANGHAI HENLIUS BIOTECH, INC.39.39%3 983
CHEMOCENTRYX, INC.39.67%3 747
ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD.64.63%3 745